retatrutide weight loss phase 2 trial results Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released demonstrating 25% in half of people with #obesity. This amount of weight loss has not been accomplished retatrutide weight loss clinical trials

Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes

Skin Quality Matters More Than the Number on the Scale A common misconception is that surgical candidacy is simply about how much you weigh

IL-23 is a cytokine involved in the inflammatory process and is considered to be associated with various chronic immune-mediated diseases

Certain factors can help determine whether youre ready for an Ozempic makeover

This hormone helps the body use insulin better to manage blood sugar and also signals to our brain that were full

A typical titration schedule might look like this: Starting Dose: You will likely begin on a low dose (e.g., 3 mg or similar starting formulation) for the first 4 weeks